HomeGERN • NASDAQ
Geron Corp
add
$1.65
0.00%
After Hours:(0.00%)0.00
$1.65
Closed: Mar 28, 7:07:04 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 47.54M | 206,582.61% |
Operating expense | 43.37M | 102.66% |
Net income | -25.35M | 51.22% |
Net profit margin | -53.33 | 99.98% |
Earnings per share | -0.04 | 60.44% |
EBITDA | -19.91M | 63.25% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 406.57M | 21.84% |
Total assets | 593.78M | 50.68% |
Total liabilities | 313.46M | 114.51% |
Total equity | 280.32M | — |
Shares outstanding | 636.90M | — |
Price to book | 3.59 | — |
Return on assets | -9.65% | — |
Return on capital | -12.83% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -25.35M | 51.22% |
Cash from operations | -43.95M | -7.35% |
Cash from investing | -103.51M | -317.60% |
Cash from financing | 166.16M | 399.29% |
Net change in cash | 18.68M | -53.18% |
Free cash flow | -16.08M | 28.55% |
Previous close
$1.65
Day range
$1.60 - $1.66
Year range
$1.46 - $5.34
Market cap
1.05B USD
Avg Volume
17.99M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Founded
1990
Headquarters
Website
Employees
229
